Abbott Laboratories’s recent filing unveils that its Officer ALLEN HUBERT L acquired Company’s shares for reported $18.72 million on Oct 21 ’24. In the deal valued at $118.89 per share,157,421 shares were bought.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Ford Robert B sold 141,679 shares, generating $16,493,218 in total proceeds. Upon selling the shares at $116.41, the CHAIRMAN AND CEO now owns 220,059 shares.
Before that, Robert B. Ford bought 141,679 shares. Abbott Laboratories shares valued at $16,492,852 were divested by the Officer at a price of $116.41 per share.
Oppenheimer initiated its Abbott Laboratories [ABT] rating to an Outperform in a research note published on October 08, 2024; the price target was $130. A number of analysts have revised their coverage, including Piper Sandler’s analysts, who began to cover the stock in mid September with a ‘”an Overweight”‘ rating. Edward Jones also remained covering ABT and has decreased its forecast on July 30, 2024 with a “Hold” recommendation from previously “Buy” rating. Goldman started covering the stock on May 30, 2024. It rated ABT as “a Buy”.
Price Performance Review of ABT
On Monday, Abbott Laboratories [NYSE:ABT] saw its stock fall -2.01% to $116.99. Over the last five days, the stock has lost -0.22%. Abbott Laboratories shares have risen nearly 6.29% since the year began. Nevertheless, the stocks have risen 22.58% over the past one year. While a 52-week high of $121.64 was reached on 03/08/24, a 52-week low of $91.64 was recorded on 07/18/24. SMA at 50 days reached $114.05, while 200 days put it at $110.48.
Levels Of Support And Resistance For ABT Stock
The 24-hour chart illustrates a support level at 116.09, which if violated will result in even more drops to 115.18. On the upside, there is a resistance level at 118.41. A further resistance level may holdings at 119.82. The Relative Strength Index (RSI) on the 14-day chart is 56.45, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 2.41, which suggests price will go up in the next trading period. Percent R suggests that price movement has been low at 35.01%. Stochastics %K at 79.52% indicates the stock is a holding.
How much short interest is there in Abbott Laboratories?
A steep rise in short interest was recorded in Abbott Laboratories stocks on 2024-09-30, dropping by -0.92 million shares to a total of 11.83 million shares. Yahoo Finance data shows the prior-month short interest on 2024-08-30 was 12.75 million shares. There was a decline of -7.82%, which implies that there is a negative sentiment for the stock.
